Cadila Healthcare is expected to post 15.9% growth in net sales to Rs. 1,558cr on the back of robust growth on the exports front. On the OPM front, we expect the company's OPM to expand by 220bp yoy to 19.2% on the back of favourable product mix. The net profit is expected to decrease by 14.3% yoy to Rs. 146cr, on back of higher tax outgo.
We maintain our buy with a target of Rs. 962.
